nomegestrol acetate has been researched along with Drug Withdrawal Symptoms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Korver, T; Mansour, D; Melis, GB; Sommer, W; Sundström-Poromaa, I; Taneepanichskul, S; Verhoeven, C; Weisberg, E | 1 |
Fraser, DI; Padwick, ML; Pryse-Davies, J; Ryder, TA; White, J; Whitehead, MI | 1 |
2 trial(s) available for nomegestrol acetate and Drug Withdrawal Symptoms
Article | Year |
---|---|
Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Menstrual Cycle; Metrorrhagia; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnadienes; Pregnancy; Pregnancy Rate; Substance Withdrawal Syndrome; Young Adult | 2011 |
The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy.
Topics: Adult; DNA; Dose-Response Relationship, Drug; Double-Blind Method; Endometrium; Estradiol; Estradiol Dehydrogenases; Female; Humans; Isocitrate Dehydrogenase; Megestrol; Menopause; Middle Aged; Norpregnadienes; Prospective Studies; Random Allocation; Receptors, Estradiol; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1989 |